2023 annual financial data
Immuneering 2023 Net margin
Direct answer
Net margin was -11,752,004.84%.
Operating income was -58,412,887 USD and net income was -53,471,622 USD.
Operating cash flow was -48,968,634 USD.
Get free Immuneering email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 455 USD
- Operating income
- -58,412,887 USD
- Net income
- -53,471,622 USD
- Operating cash flow
- -48,968,634 USD